Predictors of Treatment Response to Anti-VEGF Therapy for Choroidal Neovascularization Secondary to Chronic Central Serous Chorioretinopathy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The British Journal of Ophthalmology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Predictors of Treatment Response to Intravitreal Anti-Vascular Endothelial Growth Factor (Anti-VEGF) Therapy for Choroidal Neovascularisation Secondary to Chronic Central Serous Chorioretinopathy
Br J Ophthalmol 2019 Oct 15;[EPub Ahead of Print], K Romdhane, M Zola, A Matet, A Daruich, M Elalouf, F Behar-Cohen, I MantelFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.